Chelsea Therapeutics International Delisted
Chelsea Therapeutics International is a pharmaceutical company that focuses on developing and commercializing therapeutics for various human diseases. Their main goal is to acquire, develop, and market products for the treatment of conditions such as neurogenic orthostatic hypotension, autoimmune disorders, and cancer. They are currently working on the development of droxidopa for symptomatic NOH and other potential indications, as well as non-metabolized antifolate compounds for rheumatoid arthritis. Chelsea Therapeutics International aims to provide innovative solutions for patients suffering from these diseases.
Funding Status:
M&A
Industry:
PharmTech
Technology:
Cancer
Headquarters:
Charlotte, North Carolina, United States
Founded Date:
2004
Employee Number:
11-50